ESSA Pharma Inc.
(EPIX)
undefined
undefined%
At close: undefined
1.64
-1.20%
After-hours Dec 13, 2024, 04:00 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
Revenue | - | - | - | - | - | - | - | 217.00 | - | - | - | - |
Cost of Revenue | 118.49K | 121.79K | 109.46K | 110.32K | - | 34.49K | 46.15K | 66.18K | - | - | - | - |
Gross Profit | -118.49K | -121.79K | -109.46K | -110.32K | - | -34.49K | -46.15K | -65.96K | - | - | - | - |
Operating Income | -32.13M | -35.34M | -36.91M | -23.12M | -12.15M | -10.80M | -11.65M | -19.64M | -9.31M | -1.82M | -1.36M | -1.94K |
Interest Income | 5.55M | 1.74M | 235.00K | 559.72K | 26.25K | 42.73K | - | - | 618.25 | 217.00 | 1.31K | 1.42 |
Pretax Income | -26.58M | -35.22M | -36.84M | -23.73M | -10.40M | -11.60M | -4.38M | -12.99M | -8.57M | -1.82M | -1.37M | -1.94K |
Net Income | -26.58M | -35.10M | -36.81M | -23.45M | -10.44M | -11.63M | -4.50M | -13.14M | -8.57M | -1.82M | -1.37M | -1.94K |
Selling & General & Admin | 10.81M | 12.54M | 12.78M | 11.37M | 5.47M | 5.93M | 5.14M | 5.64M | 3.70M | 1.04M | 371.18K | 298.27 |
Research & Development | 21.32M | 24.41M | 24.26M | 12.15M | 6.70M | 4.87M | 5.73M | 13.06M | 4.39M | 671.60K | 1.59M | 1.76K |
Other Expenses | - | 1.74M | 109.46K | 515.00K | 35.00K | -40.00K | -37.00K | 79.00K | 1.15M | - | - | - |
Operating Expenses | 32.13M | 36.96M | 37.14M | 23.52M | 12.17M | 10.80M | 10.87M | 18.70M | 9.23M | 1.74M | 1.37M | 1.94K |
Interest Expense | 6.94K | 14.00K | 22.22K | 618.00K | 603.00K | 912.00K | 785.00K | 938.00K | 77.77K | 87.59K | - | - |
Selling & Marketing Expenses | 22.57K | - | - | - | - | - | - | - | - | - | 21.83K | 22.96 |
Cost & Expenses | 32.13M | 36.96M | 37.14M | 23.52M | 12.17M | 10.80M | 10.87M | 18.70M | 9.23M | 1.74M | 1.37M | 1.94K |
Income Tax | 1.60K | -112.00K | -34.35K | -289.00K | 38.00K | 27.00K | 116.00K | 151.00K | 77.77K | 87.59K | 0.28 | - |
Shares Outstanding (Basic) | 44.09M | 44.04M | 38.48M | 22.44M | 8.43M | 4.57M | 1.45M | 1.35M | 917.65K | 784.38K | 784.00K | 732.00 |
Shares Outstanding (Diluted) | 44.09M | 44.04M | 38.48M | 22.44M | 8.43M | 4.57M | 1.45M | 1.35M | 917.65K | 784.38K | 784.38K | 732.65 |
EPS (Basic) | -0.6 | -0.8 | -0.96 | -1.04 | -1.24 | -2.55 | -3.09 | -9.77 | -9.34 | -2.33 | -1.75 | -2.65 |
EPS (Diluted) | -0.6 | -0.8 | -0.96 | -1.04 | -1.24 | -2.55 | -3.09 | -9.77 | -9.34 | -2.33 | -1.75 | -2.65 |
EBITDA | -26.46M | -35.08M | -36.71M | -23.01M | -12.13M | -10.77M | -3.55M | -18.67M | -9.38M | -1.76M | -1.34M | -1.91K |
Depreciation & Amortization | 118.49K | 121.79K | 109.46K | 110.32K | 18.30K | 34.49K | 46.15K | 66.18K | 39.10K | 23.39K | 24.62K | 25.41 |